Oliver Waidmann Selected Research

Oliver Waidmann Research Topics

Disease

30	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 05/2012
17	Neoplasms (Cancer) 03/2022 - 03/2005
12	Liver Diseases (Liver Disease) 12/2023 - 10/2013
12	Fibrosis (Cirrhosis) 12/2022 - 01/2015
7	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 09/2011
6	Infections 12/2023 - 09/2011
6	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 03/2016
5	Liver Neoplasms (Liver Cancer) 04/2021 - 06/2013
5	End Stage Liver Disease 10/2017 - 09/2012
4	Carcinoma (Carcinomatosis) 06/2020 - 02/2011
3	Virus Diseases (Viral Diseases) 12/2023 - 09/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2018
3	Inflammation (Inflammations) 10/2020 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2005
3	Chronic Hepatitis C 10/2013 - 09/2011
2	Chronic Hepatitis B 12/2022 - 10/2013
2	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 01/2018
2	Disease Progression 01/2022 - 01/2016
2	Hypoxia (Hypoxemia) 01/2018 - 07/2017
2	Hemolysis 03/2016 - 01/2013
2	Carcinogenesis 06/2013 - 05/2012
1	Persistent Infection 12/2023
1	Pathologic Constriction (Stenosis) 08/2022
1	Cholangitis 08/2022
1	Hepatic Encephalopathy 05/2022
1	Hemorrhage 05/2022
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 05/2022
1	Varicose Veins (Varicose Vein) 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022
1	Liver Failure 02/2022
1	Anus Neoplasms (Anal Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Fistula 03/2021
1	Cholangiocarcinoma 06/2020
1	Hepatitis C 11/2019

Drug/Important Bio-Agent (IBA)

8	Sorafenib (BAY 43-9006)FDA Link 07/2021 - 02/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
5	MicroRNAs (MicroRNA)IBA 10/2020 - 05/2012
5	Indicators and Reagents (Reagents)IBA 10/2016 - 05/2013
4	Bevacizumab (Avastin)FDA Link 12/2022 - 03/2016
4	NivolumabIBA 01/2022 - 12/2018
4	Antiviral Agents (Antivirals)IBA 11/2019 - 06/2017
4	C-Reactive ProteinIBA 01/2016 - 05/2013
3	atezolizumabIBA 12/2022 - 01/2022
3	AntibodiesIBA 03/2022 - 03/2016
3	ErbB Receptors (EGF Receptor)IBA 03/2022 - 03/2016
3	Gemcitabine FDA Link 01/2022 - 01/2018
3	regorafenibIBA 09/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 10/2020 - 09/2011
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2018
3	SphingolipidsIBA 11/2019 - 01/2015
2	Hepatitis B e AntigensIBA 12/2023 - 10/2013
2	AntigensIBA 12/2023 - 10/2013
2	Serum AlbuminIBA 01/2023 - 09/2011
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2021
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2021 - 10/2017
2	InterferonsIBA 05/2018 - 05/2012
2	Carbonic Anhydrase IXIBA 01/2018 - 07/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 05/2012
2	B7-H1 AntigenIBA 01/2018 - 01/2016
2	Ribavirin (Virazole)FDA LinkGeneric 06/2017 - 05/2012
2	CeramidesIBA 04/2016 - 01/2015
2	Gadolinium DTPA (Magnevist)FDA Link 08/2015 - 02/2015
2	hydroxide ionIBA 01/2015 - 10/2013
2	Vitamin D FDA LinkGeneric 01/2015 - 10/2013
2	Interleukin-22 (IL-22)IBA 03/2014 - 09/2012
1	CytokinesIBA 12/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2023
1	InterleukinsIBA 12/2023
1	Surface Antigens (Surface Antigen)IBA 12/2023
1	Interleukin-12 (IL 12)IBA 12/2023
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	lenvatinibIBA 06/2022
1	folfirinoxIBA 01/2022
1	Phosphotransferases (Kinase)IBA 09/2021
1	trifluridine tipiracil drug combinationIBA 09/2021
1	cabozantinibIBA 07/2021
1	allogenic effect factor (AEF)IBA 03/2021
1	SolutionsIBA 03/2021
1	paragonIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	pembrolizumabIBA 01/2019
1	IpilimumabIBA 12/2018

Therapy/Procedure

16	Therapeutics 12/2022 - 05/2012
6	Liver Transplantation 08/2022 - 02/2011
6	Drug Therapy (Chemotherapy) 01/2022 - 08/2015
6	Immunotherapy 01/2022 - 01/2016
3	Surgical Instruments (Clip) 11/2013 - 06/2013
2	Aftercare (After-Treatment) 05/2018 - 06/2017
2	Radiotherapy 01/2018 - 03/2016
1	Transplantation 08/2022
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2022
1	Stents 05/2022
1	Ligation 05/2022
1	Contraindications 05/2022
1	Transjugular Intrahepatic Portasystemic Shunt 05/2022
1	Endovascular Aneurysm Repair 03/2021